AKTX

Akari Therapeutics
AKTX

13 hedge funds and large institutions have $16.2M invested in Akari Therapeutics in 2014 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $
Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.86M
2
+$831K
3
+$186K
4
PCM
Prelude Capital Management
New York
+$12K
5
TRCT
Tower Research Capital (TRC)
New York
+$6.43K

Top Sellers

1
-$49.4K
2
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$4.51M
2
$3.86M
3
$3.71M
4
$2.92M
5
$639K
6
$272K
7
$186K
8
$78K
9
$12K
10
$9K
11
$6K
12
$3K
13
$1K